These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 7706473)

  • 1. Cisplatin-associated anemia: an erythropoietin deficiency syndrome.
    Wood PA; Hrushesky WJ
    J Clin Invest; 1995 Apr; 95(4):1650-9. PubMed ID: 7706473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cisplatin on erythropoietin production in rats.
    Unami A; Nishina N; Terai T; Sato S; Tamura T; Noda K; Mine Y
    J Toxicol Sci; 1996 Aug; 21(3):157-65. PubMed ID: 8887884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cadmium and cisplatin damage erythropoietin-producing proximal renal tubular cells.
    Horiguchi H; Oguma E; Kayama F
    Arch Toxicol; 2006 Oct; 80(10):680-6. PubMed ID: 16555044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin ameliorates anemia of cisplatin induced acute renal failure.
    Baldwin MD; Zhou XJ; Ing TS; Vaziri ND
    ASAIO J; 1998; 44(1):44-7. PubMed ID: 9466500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum erythropoietin levels in gynecologic cancer patients during cisplatin combination chemotherapy.
    Hasegawa I; Tanaka K
    Gynecol Oncol; 1992 Jul; 46(1):65-8. PubMed ID: 1634143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin enhances recovery from cisplatin-induced acute renal failure.
    Vaziri ND; Zhou XJ; Liao SY
    Am J Physiol; 1994 Mar; 266(3 Pt 2):F360-6. PubMed ID: 8160783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies.
    Henry DH; Abels RI
    Semin Oncol; 1994 Apr; 21(2 Suppl 3):21-8. PubMed ID: 8202722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant erythropoietin rapidly treats anemia in ischemic acute renal failure.
    Nemoto T; Yokota N; Keane WF; Rabb H
    Kidney Int; 2001 Jan; 59(1):246-51. PubMed ID: 11135077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin reduces cumulative nephrotoxicity from cisplatin and enhances renal tubular cell proliferation.
    Zafirov D; Petrusevska G; Sikole A; Trojacanec J; Labacevski N; Kostova E; Jakovski K; Atanasovska E; Petrov S
    Prilozi; 2008 Dec; 29(2):167-83. PubMed ID: 19259045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin deficiency and relative resistance cause anaemia in post-renal transplant recipients with normal renal function.
    Nampoory MR; Johny KV; al-Hilali N; Seshadri MS; Kanagasabhapathy AS
    Nephrol Dial Transplant; 1996 Jan; 11(1):177-81. PubMed ID: 8649630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of anemia and its relationship with renal function, blood pressure, and erythropoietin in rats with chronic kidney disease.
    Phillips JK; Boyd R; Krockenberger MB; Burgio G
    Vet Clin Pathol; 2015 Sep; 44(3):342-54. PubMed ID: 26292198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoproduction of erythropoietin contributes to anemia in chronic cadmium intoxication: clinical study on Itai-itai disease in Japan.
    Horiguchi H; Teranishi H; Niiya K; Aoshima K; Katoh T; Sakuragawa N; Kasuya M
    Arch Toxicol; 1994; 68(10):632-6. PubMed ID: 7857202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the serum erythropoietin levels in chemotherapy-naive and cisplatin-treated cancer patients.
    Arslan M; Evrensel T; Kurt E; Demiray M; Ercan I; Kanat O; Ozkan A; Manavoglu O
    Neoplasma; 2005; 52(1):43-5. PubMed ID: 15739025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anemia following renal transplantation: erythropoietin response and iron deficiency.
    Miles AM; Markell MS; Daskalakis P; Sumrani NB; Hong J; Sommer BG; Friedman EA
    Clin Transplant; 1997 Aug; 11(4):313-5. PubMed ID: 9267720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum erythropoietin and erythroid activity in vitamin B12 deficiency.
    Remacha AF; Bellido M; García-Die F; Marco N; Ubeda J; Gimferrer E
    Haematologica; 1997; 82(1):67-8. PubMed ID: 9107086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum erythropoietin and creatinine concentrations as predictive factors for response to recombinant human erythropoietin treatment in anaemic tumour patients on chemotherapy.
    Fjornes T; Wiedemann GJ; Sack K; Jelkmann W
    Oncol Rep; 1998; 5(1):81-6. PubMed ID: 9458299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of phenylhydrazine or phlebotomy on peripheral blood, bone marrow and erythropoietin in Wistar rats.
    Criswell KA; Sulkanen AP; Hochbaum AF; Bleavins MR
    J Appl Toxicol; 2000; 20(1):25-34. PubMed ID: 10641014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mouse model for an erythropoietin-deficiency anemia.
    Zeigler BM; Vajdos J; Qin W; Loverro L; Niss K
    Dis Model Mech; 2010; 3(11-12):763-72. PubMed ID: 20959632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury.
    Salahudeen AK; Haider N; Jenkins J; Joshi M; Patel H; Huang H; Yang M; Zhe H
    Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1354-65. PubMed ID: 18385271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin deficiency: a complication of cisplatin therapy and its treatment with recombinant human erythropoietin.
    Bray GL; Reaman GH
    Am J Pediatr Hematol Oncol; 1991; 13(4):426-30. PubMed ID: 1785669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.